This is the text extract for Proposal regarding insulin pen needles and disposable insulin syringes. Closed, browse documents here.

27 August 2010

Proposal regarding insulin pen needles and disposable insulin syringes

PHARMAC is seeking feedback on a proposal to: • • fully fund a new, finer gauge insulin pen needle (32 g x 4 mm); and amend the terms of supply for the existing range of BD insulin pen needles and BD disposable insulin syringes.

Further details of the proposals can be found below and on the following page. Feedback sought PHARMAC welcomes feedback on this proposal. To provide feedback, please submit it in writing by Friday, 10 September 2010 to: Greg Williams Therapeutic Group Manager PHARMAC Email: greg.williams@pharmac.govt.nz Fax: 04 460 4995 Post: PO Box 10 254, Wellington 6143

All feedback received before the closing date will be considered by PHARMAC’s Board (or Chief Executive acting under delegated authority) prior to making a decision on this proposal. Details of the proposal PHARMAC has entered into a provisional agreement with Becton Dickinson Limited (BD) to list a new gauge of insulin pen needles in Section B and Part II of Section H of the Pharmaceutical Schedule from 1 November 2010 at the following price and subsidy (exmanufacturer, excluding GST):

Chemical Insulin pen needles

Size 32 g x 4 mm

Brand B-D Micro-Fine

Pack size 100

Price and subsidy $10.50

It is proposed that the existing range of BD insulin pen needles and BD disposable insulin syringes listed in Part B of the Pharmaceutical Schedule would also be listed in Part II of Section H with no change in price or pack size. The current restrictions that apply to insulin pen needles and disposable insulin syringes would remain and would be applied to the listing of the 32 g x 4 mm insulin pen needles. The entire range of BD insulin pen needles (including the 32 g x 4 mm insulin pen needles) and disposable insulin syringes would have protection from delisting and subsidy reduction until 1 January 2013.

A377231 - T10-490 Page 1 of 2

Background to the proposal Insulin pen needles and disposable insulin syringes are subsidised for patients using insulin for the treatment of diabetes mellitus. A range of sizes of insulin pen needles are already fully funded on the Pharmaceutical Schedule. The funding of the 32 g x 4 mm insulin pen needle would result in it being the shortest and thinnest insulin pen needle funded in New Zealand. The BD insulin pen needles are compatible with all insulin pens used in New Zealand.

A377231 - T10-490

Page 2 of 2